2-(2-Chloropyrimidin-4-yl)propan-2-ol

Catalog No.: 
ACYXCT450
CAS No.: 
1312535-77-5
Molecular Formula: 
C7H9ClN2O
Molecular Weight: 
172.62
2-(2-Chloropyrimidin-4-yl)propan-2-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$205.00In stockInquiry
250mg98%$344.00In stockInquiry
1g98%$745.00In stockInquiry
5g98%$2658.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chloropyrimidin-4-yl)propan-2-ol
IUPAC Name2-(2-chloropyrimidin-4-yl)propan-2-ol
MDL No.MFCD26403248
Molecular FormulaC7H9ClN2O
Molecular Weight172.62
SMILESCC(C)(C1C=CN=C(Cl)N=1)O
InChI KeyDDZANYFTNLKQOK-UHFFFAOYSA-N
Synonym2-(2-chloropyrimidin-4-yl)propan-2-ol;4-Pyrimidinemethanol, 2-chloro-α,α-dimethyl-
CAS No.1312535-77-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYXCT450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAUBC925 route compound structure diagram
    ACAUBC925149849-94-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYXCT450 route product structure diagram
    ACYXCT4501312535-77-5In Stock
Inquiry

2. ACYXCT450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRBVN453 route compound structure diagram
    ACRBVN4531312535-78-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYXCT450 route product structure diagram
    ACYXCT4501312535-77-5In Stock
Inquiry

3. ACYXCT450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYXCT450 route product structure diagram
    ACYXCT4501312535-77-5In Stock
Inquiry

Comments (0)